Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

被引：1
|
作者：
Saad, Eddy
Labaki, Chris
Miron, Benjamin
Park, Jihye
Bakouny, Ziad
Nassar, Amin
Saliby, Renee Maria
Semaan, Karl
Eid, Marc
Meli, Kevin
Laimon, Yasmin Nabil
Geynisman, Daniel M.
Kokate, Rutika
Braun, David A.
Signoretti, Sabina
Mcgregor, Bradley Alexander
Plimack, Elizabeth R.
Choueiri, Toni K.
Van Allen, Eliezer Mendel
Zibelman, Matthew R.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Harvard Univ, Cambridge, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
[8] Yale Univ, New Haven, CT USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[10] Fox Chase Canc Ctr, Temple Hlth, Philadelphia, PA USA
[11] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-9200; 3282-206-3691-5663-4986; 613-225-3248-9559-9794; 3282-206-3691-2722-5055; 3282-646-4685-2628; 5; 3; 2; 38092-18323; 38092-27449; 38092-23384;
D O I：
10.1200/JCO.2024.42.4_suppl.459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pathologic response and surgical outcomes in patients undergoing nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.
    Margulis, Vitaly
    Singla, Nirmish
    Elias, Roy
    Ghandour, Rashed
    Freifeld, Yuval N.
    Bowman, I. Alex
    Woldu, Solomon L.
    Gahan, Jeffrey
    Bagrodia, Aditya
    Brugarolas, James
    Hammers, Hans J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Genomic and neoantigen evolution and resistance to immune checkpoint blockade in metastatic renal cell carcinoma
    Miao, Diana
    De Velasco, Guillermo
    Adeegbe, Dennis
    Norton, Craig
    Martini, Dylan
    Mullane, Stephanie
    Moreira, Raphael
    Signoretti, Sabina
    Wong, Kwok-Kin
    Choueiri, Toni
    Van Allen, Eliezer
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [43] Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Paderi, Agnese
    Giorgione, Roberta
    Giommoni, Elisa
    Mela, Marinella Micol
    Rossi, Virginia
    Doni, Laura
    Minervini, Andrea
    Carini, Marco
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    CANCERS, 2021, 13 (04) : 1 - 11
  • [44] Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Olsen, T. Anders
    Case, Katherine
    Magod, Benjamin L.
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Harris, Wayne B.
    Kissick, Haydn T.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet Asim
    ONCOLOGIST, 2021, 26 (10): : E1742 - E1750
  • [45] Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma
    Mason, N.
    Kim, Y.
    Shah, S.
    Adashek, J. J.
    Manley, B. J.
    Spiess, P. E.
    Chahoud, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S692 - S692
  • [46] Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
    Resch, I.
    Bruchbacher, A.
    Franke, J.
    Fajkovic, H.
    Remzi, M.
    Shariat, S. F.
    Schmidinger, M.
    ESMO OPEN, 2021, 6 (04)
  • [47] T-cell checkpoint inhibitors in metastatic renal cell carcinoma
    Gruenwald, Viktor
    CURRENT OPINION IN UROLOGY, 2015, 25 (05) : 411 - 415
  • [48] Outcome with immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
    Bruchbacher, Andreas
    Franke, Johannes
    Alic, Zumreta
    Nachbargauer, Sebastian
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] Impact of immune checkpoint inhibitor-based combination therapy on palliative care utilization for patients with metastatic renal cell carcinoma.
    Baclig, Nikita V.
    Cabral, Marsenne Y.
    Kathuria-Prakash, Nikhita
    Velez, Maria Antonia
    Pantuck, Allan J.
    Drakaki, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
    Garmezy, Benjamin
    Zhang, Tian
    Laccetti, Andrew Leonard
    Economides, Minas P.
    Shah, Amishi Yogesh
    Tannir, Nizar M.
    Jonasch, Eric
    Msaouel, Pavlos
    Zurita, Amado J.
    Corn, Paul Gettys
    Venkatesan, Aradhana M.
    Brown, Landon Carter
    Kao, Chester
    Kinsey, Emily Noelle
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Campbell, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345